MSB 2.03% $1.45 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-695

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 752 Posts.
    lightbulb Created with Sketch. 416
    It is not break if FDA approval is not granted, There are many scenarios painted by much more intelligent posters and longer term holders here than me here if FDA does not approve.
    I believe in my investments. I do believe that stemcell medicine the way Mesoblast does it is the future and the start of the future of effective medicine. That is it for me.
    Money is damned important but we all have only two options. Either hold and see how the other phase three trials go (still very possible and probable). Or sell if we don't believe money can be made <<<in the short run>>>
    I view all my investments big picture and I do believe in my DD in this company, and a political decision to stop saving lives, will never change my sentiment in MSB. The world is a big place, and the US is just a small part of it if they don't want to lead in medicine (only very worse case even though I think it is unlikely).
    Last edited by Gazdix: 25/09/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.45
Change
-0.030(2.03%)
Mkt cap ! $1.655B
Open High Low Value Volume
$1.48 $1.51 $1.43 $6.613M 4.498M

Buyers (Bids)

No. Vol. Price($)
1 2482 $1.45
 

Sellers (Offers)

Price($) Vol. No.
$1.46 27045 2
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.